ReviewCancer reports (Hoboken, N.J.)2025

A Case Series and Literature Review on Zanubrutinib Therapy for the Treatment of Relapsed/Refractory Immune Thrombocytopenia.

Bingjie Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.